Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia
Damiana Scuteri1,2, Kengo Hamamura3, Chizuko Watanabe4
1Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.
Abstract:
Murine models are fundamental in the study of clinical conditions and the development of new drugs and treatments. Transgenic technology has started to offer advantages in oncology, encompassing all research fields related to the study of painful syndromes. Knockout mice or mice overexpressing genes encoding for proteins linked to pain development and maintenance can be produced and pain models can be applied to transgenic mice to model the most disabling neurological conditions. Due to the association of movement disorders with sensitivity and pain processing, our group focused for the first time on the role of the torsinA gene GAG deletion-responsible for DYT1 dystonia-in baseline sensitivity and neuropathic responses. The aim of the present report are to review the complex network that exists between the chaperonine-like protein torsinA and the baseline sensitivity pattern-which are fundamental in neuropathic pain-and to point at its possible role in neurodegenerative diseases.
Insights
This study explores the torsinA gene
Area of Science:
- Neuroscience
- Genetics
- Pain Research
Background:
- Murine models are crucial for studying diseases and treatments.
- Transgenic technology enhances research in oncology and pain syndromes.
- DYT1 dystonia is linked to movement disorders and pain processing.
Purpose of the Study:
- To review the role of torsinA protein in baseline sensitivity and neuropathic pain.
- To investigate the connection between torsinA and pain processing.
- To explore torsinA's potential role in neurodegenerative diseases.
Main Methods:
- Utilizing transgenic mice (knockout or overexpressing torsinA).
- Applying pain models to study neurological conditions.
- Analyzing the torsinA gene's GAG deletion linked to DYT1 dystonia.
Main Results:
- TorsinA's complex network with baseline sensitivity patterns is reviewed.
- The study highlights torsinA's potential involvement in neuropathic pain.
- The possible role of torsinA in neurodegenerative diseases is indicated.
Conclusions:
- TorsinA plays a role in baseline sensitivity, fundamental to neuropathic pain.
- Further research into torsinA's function may reveal insights into neurodegenerative diseases.
- This study establishes a foundation for understanding torsinA in pain and neurological disorders.
